SEC Form 4 · accession 0001593968-19-000213
Vericel Corp · VCEL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert L Zerbe M.D.
Director
Period of report
Jan 22, 2019
Accepted (ET)
Jan 24, 2019 · 4:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000887359
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 22, 2019 | M | 17,500 | $2.63 | A | 17,545 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.63 | Jan 22, 2019 | M | 17,500 | D | — | May 3, 2027 | Common Stock | 17,500 | 0 | D |
Explanation of responses
- F1These options, representing the right to purchase a total of 17,500 shares, became exercisable in equal monthly installments, contingent upon continued service to the Company, with the first vesting date on June 3, 2017, which was one month after the date on which the option was granted.